ArticleHepatology (Baltimore, Md.)2017

The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B.

George V Papatheodoridis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.